SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Kendle International Inc. (KNDL)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Bilow who wrote (42)8/22/1999 8:42:00 AM
From: Joe Dancy  Read Replies (1) of 53
 
I like this company and this segment-less risk of a serious crash than if they were developing the drugs and seeking FDA approval - and plays well on outsouring trend and trend that now sees many more drugs in review process. In any event, after the stock has pulled back so much the valuations look compelling. Helped myself to a small portion here - how could you not when it is selling at book value with a good outlook longer term.

Biotechs are coming back into focus by the way, which will help a few quarters down the road here - theaudioinvestor.com
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News